Vered Bisker-Leib
2019
In 2019, Vered Bisker-Leib earned a total compensation of $1.1M as President and Chief Operating Officer at Compass Therapeutics.
Compensation breakdown
| Bonus | $160,875 |
|---|---|
| Salary | $325,000 |
| Stock Awards | $569,159 |
| Total | $1,055,034 |
Bisker-Leib received $569.2K in stock awards, accounting for 54% of the total pay in 2019.
Bisker-Leib also received $160.9K in bonus and $325K in salary.
Rankings
In 2019, Vered Bisker-Leib's compensation ranked 9,046th out of 13,971 executives tracked by ExecPay. In other words, Bisker-Leib earned more than 35.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,046 out of 13,971 | 35th |
Division Manufacturing | 3,626 out of 5,695 | 36th |
Major group Chemicals And Allied Products | 1,368 out of 2,194 | 38th |
Industry group Drugs | 1,166 out of 1,880 | 38th |
Industry Biological Products, Except Diagnostic Substances | 266 out of 389 | 32nd |
Source: SEC filing on April 29, 2021.
Bisker-Leib's colleagues
We found one more compensation record of an executive who worked with Vered Bisker-Leib at Compass Therapeutics in 2019.
2019
Thomas Schuetz
Compass Therapeutics